Research
What Is a 'Liquid Biopsy'? The Blood Test Behind Cancer Headlines
Liquid biopsy is a blood test that looks for cancer's fingerprints in the bloodstream. Here's what it is, how it's used, and its current limits.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What people see in the news
"Liquid biopsy" appears in stories about blood tests that can detect cancer, track whether a treatment is working, or find cancer's return without surgery. The name is catchy, and it covers a real and fast-moving technology — with genuine limits worth knowing.
What it actually means
A traditional biopsy removes a piece of tissue to examine under a microscope. A "liquid biopsy" instead analyzes a body fluid — usually blood — for signs of cancer. When tumors grow, they can shed material into the bloodstream, including fragments of tumor DNA (called circulating tumor DNA, or ctDNA) and whole tumor cells. A liquid biopsy looks for these.
This fits into what the National Cancer Institute describes as tumor markers: substances present in or produced by cancer cells that can provide information about a cancer — such as how aggressive it is, whether it can be treated with a particular targeted therapy, or whether it's responding to treatment. Many established tumor-marker tests, NCI notes, are already run on blood samples.
In practice, liquid biopsies are most established for guiding and monitoring treatment in people who already have cancer — for example, checking a tumor's genetic features to match a targeted therapy, or watching for signs that cancer is coming back. Their use for screening healthy people is a newer and more debated frontier that overlaps with multi-cancer early detection tests still under study.
What this does and doesn't change
- Liquid biopsies are most useful today for guiding treatment and monitoring in people already diagnosed — not as a proven way to screen the general population.
- A key limitation is sensitivity: early-stage cancers may shed too little DNA to detect reliably, so a negative result doesn't rule out cancer.
- They don't replace tissue biopsies or imaging in every situation. Doctors often use them alongside, not instead of, standard tests.
- The field is advancing quickly, and specific tests differ in what they detect and how well — so results should always be interpreted with a clinician.
For proven screening — the kind shown to lower cancer deaths — our free screening check-up tool can help you see which tests apply to you.
Questions to ask a healthcare team
- Would a liquid biopsy add useful information in my situation?
- What exactly would it be looking for, and how reliable is it here?
- Does it replace or supplement a tissue biopsy or imaging?
- How should I interpret a positive or negative result?
Liquid biopsy is a genuinely promising tool with a specific, evolving role — powerful for some uses, unproven for others. Free, plain-language cancer education helps more people tell those apart.